-
Something wrong with this record ?
Effects of synthetic cathinone naphyrone in the conditioned place preference test - Evidence of its addictive potential
H. Danda, N. Pinterová-Leca, K. Šíchová, K. Štefková-Mazochová, K. Syrová, L. Olejníková, M. Končická, V. Mazoch, E. Lhotková, M. Kuchař, T. Páleníček
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Alkaloids pharmacology MeSH
- Behavior, Animal drug effects MeSH
- Conditioning, Classical drug effects MeSH
- Rats MeSH
- Methamphetamine administration & dosage pharmacology MeSH
- Disease Models, Animal MeSH
- Pentanones administration & dosage pharmacology MeSH
- Substance-Related Disorders * MeSH
- Rats, Wistar MeSH
- Pyrrolidines administration & dosage pharmacology MeSH
- Central Nervous System Stimulants administration & dosage pharmacology MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Naphyrone, also known as NRG-1, is a novel psychoactive substance (NPS), a cathinone with stimulatory properties available on the grey/illicit drug market for almost a decade. It is structurally related to infamously known powerful stimulants with the pyrovalerone structure, such as alpha-pyrrolidinovalerophenone (α-PVP) or methylenedioxypyrovalerone (MDPV) that are labeled as a cheap replacement for cocaine and other stimulants. Despite the known addictive potential of α-PVP and MDPV, there are no studies directly evaluating naphyrone's addictive potential e.g., in conditioned place preference (CPP) test or using self-administration. Therefore, our study was designed to evaluate the addictive potential in a CPP test in male Wistar rats and compare its effect to another powerful stimulant with a high addictive potential - methamphetamine. Naphyrone increased time spent in the drug-paired compartment with 5 and 20 mg/kg s.c. being significant and 10 mg/kg s.c. reaching the threshold (p = 0.07); the effect was comparable to that of methamphetamine 1.5 mg/kg s.c. The lowest dose, naphyrone 1 mg/kg s.c., had no effect on CPP. Interestingly, no dose response effect was detected. Based on these data, we are able to conclude that naphyrone has an addictive potential and may possess a significant risk to users.
3rd Faculty of Medicine Charles University Ruská 87 Prague 10 100 00 Czech Republic
National Institute of Mental Health Topolová 748 Klecany 250 67 Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010771
- 003
- CZ-PrNML
- 005
- 20231213104810.0
- 007
- ta
- 008
- 220425s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbr.2021.113713 $2 doi
- 035 __
- $a (PubMed)34906607
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Danda, Hynek, $d 1988- $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic $7 xx0311507
- 245 10
- $a Effects of synthetic cathinone naphyrone in the conditioned place preference test - Evidence of its addictive potential / $c H. Danda, N. Pinterová-Leca, K. Šíchová, K. Štefková-Mazochová, K. Syrová, L. Olejníková, M. Končická, V. Mazoch, E. Lhotková, M. Kuchař, T. Páleníček
- 520 9_
- $a Naphyrone, also known as NRG-1, is a novel psychoactive substance (NPS), a cathinone with stimulatory properties available on the grey/illicit drug market for almost a decade. It is structurally related to infamously known powerful stimulants with the pyrovalerone structure, such as alpha-pyrrolidinovalerophenone (α-PVP) or methylenedioxypyrovalerone (MDPV) that are labeled as a cheap replacement for cocaine and other stimulants. Despite the known addictive potential of α-PVP and MDPV, there are no studies directly evaluating naphyrone's addictive potential e.g., in conditioned place preference (CPP) test or using self-administration. Therefore, our study was designed to evaluate the addictive potential in a CPP test in male Wistar rats and compare its effect to another powerful stimulant with a high addictive potential - methamphetamine. Naphyrone increased time spent in the drug-paired compartment with 5 and 20 mg/kg s.c. being significant and 10 mg/kg s.c. reaching the threshold (p = 0.07); the effect was comparable to that of methamphetamine 1.5 mg/kg s.c. The lowest dose, naphyrone 1 mg/kg s.c., had no effect on CPP. Interestingly, no dose response effect was detected. Based on these data, we are able to conclude that naphyrone has an addictive potential and may possess a significant risk to users.
- 650 _2
- $a alkaloidy $x farmakologie $7 D000470
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a chování zvířat $x účinky léků $7 D001522
- 650 _2
- $a stimulanty centrálního nervového systému $x aplikace a dávkování $x farmakologie $7 D000697
- 650 _2
- $a klasické podmiňování $x účinky léků $7 D003214
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methamfetamin $x aplikace a dávkování $x farmakologie $7 D008694
- 650 _2
- $a pentanony $x aplikace a dávkování $x farmakologie $7 D010422
- 650 _2
- $a pyrrolidiny $x aplikace a dávkování $x farmakologie $7 D011759
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 12
- $a poruchy spojené s užíváním psychoaktivních látek $7 D019966
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pinterová-Leca, Nikola $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic
- 700 1_
- $a Šíchová, Klára $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
- 700 1_
- $a Štefková-Mazochová, Kristýna $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
- 700 1_
- $a Syrová, Kateřina $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic
- 700 1_
- $a Olejníková, Lucie $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
- 700 1_
- $a Končická, Markéta $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
- 700 1_
- $a Mazoch, Vladimír $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
- 700 1_
- $a Lhotková, Eva $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
- 700 1_
- $a Kuchař, Martin $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Technická 5, Prague 6 166 28, Czech Republic
- 700 1_
- $a Páleníček, Tomáš $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic. Electronic address: tomas.palenicek@nudz.cz
- 773 0_
- $w MED00000660 $t Behavioural brain research $x 1872-7549 $g Roč. 421, č. - (2022), s. 113713
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34906607 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20231213104806 $b ABA008
- 999 __
- $a ok $b bmc $g 1788748 $s 1161969
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 421 $c - $d 113713 $e 20211211 $i 1872-7549 $m Behavioural brain research $n Behav Brain Res $x MED00000660
- LZP __
- $a Pubmed-20220425